Atlas Trials

Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA

Clinical trial NCT00585364 · COMPLETED

Trial details

NCT number
NCT00585364
Sponsor
University of Pittsburgh
Status
COMPLETED
Study type
OBSERVATIONAL
Cystic FibrosisAllergic Bronchopulmonary Aspergillosis
Start date
2005-03-01
Primary completion
2010-12-01
Enrollment
79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.